Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study Thomas Decker Christensen, MD, PhD, Flemming Skjøth, PhD, Peter Brønnum Nielsen, PhD, Marianne Maegaard, RN, Erik Lerkevang Grove, MD, PhD, Torben Bjerregaard Larsen, MD, PhD The Annals of Thoracic Surgery Volume 101, Issue 4, Pages 1494-1499 (April 2016) DOI: 10.1016/j.athoracsur.2015.09.084 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Forest plot of incidence rates and adjusted hazard ratios with 95% confidence intervals. Hazard ratios adjusted for presence of hypertension (treatment), diabetes mellitus (diagnosis or treatment), vascular disease consisting of myocardial infarction, peripheral artery disease and aortic plaque, congestive heart failure or left ventricular dysfunction, ischemic stroke or systemic embolism or transient ischemic attack at time of cohort inclusion. (ref. = reference.) The Annals of Thoracic Surgery 2016 101, 1494-1499DOI: (10.1016/j.athoracsur.2015.09.084) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions